Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05369091Phase 4Completed
Phase 4, randomised trial in bone fracture (Fx) comparing Placebo with Simvastatin (2 arms). Primary endpoints: Salivary Bone Morphogenetic Protein-2 Levels at Day 40 and Radiographic Measurement of Bone Density at Day 40. Started Dec 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05369091.